Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

[email protected]+44 (0) 1665 608 579 - Office

Eleanor Row

Eleanor has over 13 years’ experience in the pharmaceutical and contract research environment working with multinational companies such as Sanofi-Aventis and Covance. Eleanor holds a PhD in Chemistry/Pharmacology from The University of Sheffield. Her subsequent postdoctoral studies were carried out at the University of Liverpool under the supervision of Dr A. Stachulski and Professor P. M. O'Neill developing novel anti-parasitic and anti-malarial compounds.

In 2006, Eleanor moved to Sanofi–Aventis gaining significant expertise in the synthesis of both radiolabelled and stabled labelled compounds. As an APM accredited Project Manager Eleanor has a proven track record for successfully delivering projects and high quality materials to Clients globally.  In addition to this, Eleanor manages our diligent team of proposal specialists and CMC regulatory scientists.  

“Working with our Clients across our range of diverse and integrated services is a hugely rewarding experience, every day brings a new and exciting challenge”

What Customers Said